Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist

Invertebrate Neuroscience

Volumn 3, Issue 2-3, 1997, Pages 251-259

  Kem, William R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's therapy; Anabaseine; Drug design; GTS 21; Nemertine; Nicotinic receptor

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ALPHA BUNGAROTOXIN; ANABASINE; NICOTINIC AGENT; TETRODOTOXIN; TOXIN;

ALZHEIMER DISEASE; BIOAVAILABILITY; CONFERENCE PAPER; DRUG DESIGN; IMMUNE RESPONSE; INVERTEBRATE; MOLECULAR SIZE; NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANABASINE; ANIMALS; DRUG DESIGN; HUMANS; INVERTEBRATES; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; TOXINS, BIOLOGICAL;

EID: 0031371159     PISSN: 13542516     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02480382     Document Type: Conference Paper

References (39)

1. Abood, L. G., Reynolds, D. T., Booth, H. and Bidlock, J. M. (1981) Sites and mechanisms for nicotine's action in the brain. Neurosci. Behav. Rev., 5, 479-486.
2. Arendash, G. W., Sengstock, G. J., Sanberg, P. R., and Kem, W. R. (1995) Improved learning and memory in aged rats with chronic administration of the nicotmic receptor agonist GTS-21. Brain Res., 674, 252-259.
3. Arneric, S. P., Sullivan, J. P., and Williams, M. (1995) Neuronal nicotinic acetylcholine receptors. Novel targets for CNS therapeutics. Ch. 9, In Psychopharmacology: The Fourth Generation of Progress, ed. F. E. Bloom and D. J. Kupfer, pp 95-110. New York: Raven Press.
4. Bacq, Z. M. (1936) Les poisons des Nemertiens. Bull. Acad. R. Belg. Cl. Sci. (Ser. 5), 22, 1072-1079.
5. Bacq, Z. M. (1937) L"amphiporine' et la 'nemertine,' poisons des vers nemertiens. Arch. Int. Physiol., 44, 190-204.
6. Bjugstad, K. B., Mahnir, V. M., Kem, W. R., and Arendash, G. W. (1996) Long-term treatment with GTS-21 or nicotine enhances water maze performance in aged rats without affecting the density of nicotinic receptor subtypes in neocortex. Drug Dev. Res., 39, 19-28.
7. 3H]N-methyl-carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain. Eur. J. Phamacol., 139, 323-333.
8. 125K] alpha-Bungarotoxin receptor subtypes. Mol. Pharmacol., 47, 164-171.
9. Jansson, A. M., Fuxe, K., Agnati, L. F., Kitayama, I., Harfstrand, A., Andersson, K., Goldstein, M. (1988) Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection. Brain Res., 455, 332-345.
10. Kem, W. R. (1971) A study of the occurrence of anabaseine in Paranemertes and other nemertines. Toxicon, 9, 23-32.
11. Kem, W. R. (1973) Biochemistry of Nemertine Toxins, In: Marine Pharmacognosy: Marine Biotoxins as Probes of Cellular Function, ed. D. F. Martin and G. M., Padilla, pp 37-84. Monographs on Cell Biology Series. New York: Academic Press.
12. Kem, W. R. (1988a) Worm toxins. In: Handbook of Natural Toxins, Vol. 4, Marine Toxins and Venoms, ed. Marcel Dekker Tu, pp 253-378.
13. Kem, W. R. (1988b) Peptide chain toxins of marine animals. In: Biomedical Importance of Marine Organisms, ed. D. Fautin. Mem. Calif. Acad. Sci. 13, 69-83.
14. Kem, W. R., Abbott, B. C. and Coates, R. M. (1971) Isolation and structure of a hoplonemertine toxin. Toxicon, 9, 15-22.
15. Kem, W. R., Scott, K. N. and Duncan, J. H. (1976) Hoplonemertine worms - a new source of pyridine neurotoxins. Experientia, 32, 684-686.
16. Kem, W. R., Mahnir, V. M., Bloom, L. B., and Gabrielson, B. J. (1994a) The active form of the nicotinic receptor agonist anabaseine is the cyclic iminium cation. 11th World Congress on Animal, Plant, and Microbial Toxins, Tel Aviv.
17. Kem, W. R., Mahnir, V. M., and Lin, B. (1994b) Interaction of DMXBA (GTS-21), a cognition-enhancing compound, with cholinergic receptors. Soc. Neurosci., Nov, 13-18.
18. Kem, W. R., Mahnir, V. M., Lin, B., and Prokai-Tatrai, K. (1996) Two primary GTS-21 metabolites are potent partial agonists at alpha7 nicotinic receptors expressed in the Xenopus oocyte. J. Neurosci., 22, 268 (Abstr. 110.7)
19. Kem, W. R., Mahnir, V. M., Papke, R. and Lingle, C. (1997) Anabaseine is a potent agonist upon muscle and neuronal alpha-bungarotoxin sensitive nicotinic receptors. J. Pharmacol. Exper. Therap., 283, 979-992.
20. King, H. (1939) Amphiporine, an active base from the marine worm Amphiporus lactifloreus. J. Chem. Soc., 1365.
21. Lang, W., and Henke, H. (1983) Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Res., 267, 271-280.
22. Machu, T. K., Strahlendorf, J., and Kem, W. R. (1996) Nicotinic receptor ligands antagonize 5-HT3 receptors expressed in Xenopus oocytes. J. Neurosci., 22, (Abstr.).
23. Mahnir, V. M., Lin, B., Prokai-Tatrai, K., and Kem, W. R. (1998) Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing cognition. Biopharm. Drug Disp. (in press).
24. Martin, E. J., Panickar, K. S., King, M. A., Deyrup, M., Hunter, B. E., Wang, G., and Meyer, E. M. (1994) Cytoprotective actions of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons. Drug Dev. Res., 31, 135-141.
25. Meyer, W. M., De Fiebre, C. M., Hunter, B. E., Simpkins, C. E., Frauworth, N., and DeFiebre, N. E. (1994) Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev. Res., 31, 127-134.
26. Newhouse, P. A., Potter, A., and Lenox, R. H. (1993) The effects of nicotinic agents on human cognition: possible therapeutic applications in Alzheimer's and Parkinson's Diseases. Med. Chem. Res., 2, 628-642.
27. Orr-Urtreger, A., Goldner, F. M., Saeki, M., Lorenze, I., Goldberg, L., De Biasi, M., Dani, J. A., Patrick, J. W., and Beaudet, A. L. (1997) Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci., 17, 9165-9171.
28. Papke, R. L., de Fiebre, C. M., Kem, W. R., and Meyer, E. M. (1994) The subunit specific effects of novel anabaseine-derived nicotinic agents. In Alzheimer Disease: Therapeutic Strategies, ed. E. Giacobini and R. Becker, pp 206-211. Boston: Birkhauser.
29. Picciotto, M. R., Zoll, M., Lena, C., Bessis, A., Lallemand, Y., LeNovere, N., Vincent, P., Pich, E. M., Brulet, P., and Changeux, J.-P. (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature, 374, 65-67.
30. Spath, E., and Mamoli, L. (1936) Eine Neue Synthese Des D,L-Anabasins. Chem. Ber., 69, 1082-1085.
31. Stevens, K. E., Kern, W. R., Mahnir, V. M., and Freedman, R. (1998) Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacol. (in press).
32. Sugaya, K., Gicaobini, E., and Chiappinelli, V. A. (1990) Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. J. Neurosci. Res., 27, 349-359.
33. Summers, K., Kem, W. R., and Giacobini, E. (1997) Nicotinic agonist modulation of neurotransmitter levels in the rat frontoparietal cortex. Jap. J. Pharmacol., 74, 139-146.
34. Wheeler, J. W., Olubajo, O., Storm, C. B., and Duffield, R. M. (1981) Anabaseine: venom alkaloid of Aphaenogaster ants. Science, 211, 1051-1052.
35. Whitehouse, R. J., Price, D. L., Clark, A. W., Coyle, J. T., and DeLong, M. R. (1986) Nicotinic acetylcholine binding in Alzheimer's disease. Brain Res., 371, 146-151.
36. Woodruff-Pak, D. S., Li, Y-T., Kazmi, A., and Kem, W. R. (1994a) Nicotinic cholinergic system involvement in eyeblink classical conditioning in rabbits. Behav. Neurosci., 108, 486-493.
37. Woodruff-Pak, D. S., Li, Y-T., and Kem, W. R. (1994b) A nicotinic receptor agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res., 645, 309-317.
38. Zoltewicz, J. A., Bloom, L. B. and Kem, W. R. (1989) Quantitative determination of the ring-chain hydrolysis equilibrium constant for anabaseine and related tobacco alkaloids. J. Org. Chem., 54, 4462-4468.
39. Zoltewicz, J. A., Prokai-Tatrai, K., Bloom, L. B. and Kem, W. R. (1993) Long range transmission of polar effects of cholinergic 3-arylideneanabaseines. Conformations molecular modelling. Heterocycles, 35, 171-179.